Ember Therapeutics Competitors and Similar CompaniesClear all

Ember Therapeutics's competitors and similar companies include Diasome, Novaremed, Hua Medicine and Kadimastem.
Ember Therapeutics
Ember Therapeutics
Ember Therapeutics is a biopharmaceutical company that develops regenerative medicines.
Diasome
Diasome
Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
Novaremed
Novaremed
Novaremed is a clinical-stage biopharmaceutical company.
Hua Medicine
Hua Medicine
Hua Medicine (华领医药) is a drug development company.
Kadimastem
Kadimastem
Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).
Founding Date
Founding Date
2011
Founding Date
2004
Founding Date
2017
Founding Date
2011
Founding Date
2009
Type
Type
Public
Type
Private
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
Cleveland, US HQ
Locations
Basel, CH HQ
Locations
Shanghai, CN HQ
Beijing, CN
Wuhan, CN
Hong Kong, HK
Locations
Ness Ziona, IL HQ
Employees
Employees
N/A
Employees
1515% increase
Employees
10
Employees
168
Employees
11

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
¥492.9m (FY, 2025)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥180.1m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
¥1.6b (FY, 2025)
Gross profit
N/A
Net income
Net income
N/A
Net income
N/A
Net income
N/A
Net income
¥1.1b (FY, 2025)
Net income
(₪26.6m) (FY, 2024)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 30m (almost 9 years ago)
Latest funding round
$ 2.6m (almost 7 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 34m
Total funding raised
$ 42.9m
Total funding raised
$ 13.3m
Total funding raised
$ 242.4m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Diasome
HQ
Cleveland, US
Employees
15↑ 15% increase

Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.

View company
Novaremed
HQ
Basel, CH
Employees
10

Novaremed is a clinical-stage biopharmaceutical company.

View company
Hua Medicine
HQ
Shanghai, CN
Employees
168

Hua Medicine (华领医药) is a drug development company.

View company
Kadimastem
HQ
Ness Ziona, IL
Employees
11

Kadimastem is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells (hESCs).

View company